Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • casual_seqs
    Junior Member
    • Jun 2009
    • 5

    Adaptor technologies comparison

    Hello,
    I am interested in the comparison/respective advantages and weak points of the various adapters technologies, from the point of view of in-vitro genomic libraries construction and amplification, the avoidance of artifacts, and ease of preparation.

    1°) anyone with a synthetic view on this (including the adapter technologies of Solexa, Illumina, Solid, etc...) ?
    I am interested in the finicky details also (eventual exo protection, eventual 3'-end and/or 5'-end modification, etc...)

    2°) about the Solid adaptors:(see also http://seqanswers.com/forums/showthread.php?t=588)

    I have read in this forum (http://seqanswers.com/forums/showthread.php?t=198, sci_guy), that the solid adaptors are non-phosphorylated, so that P1-P1, P2-P2, or P1-P2 dimers are not formed at the ligation step; (by the way, are the 3'TT-overhangs efficient at avoiding ligation to genomic DNA ?)
    Also, for the amplification steps, the targets of the primers are generated by nick translation.
    Those features appears clever; Does this technique readily outperforms the competitor's adapters technologies ?

    3°) Would someone have the detailled solid protocol for library prep at hand (under electronic form), that could be forwarded/downloaded/or pasted in this thread?
  • casual_seqs
    Junior Member
    • Jun 2009
    • 5

    #2
    I transferred this post to
    Techniques and protocol discussions on sample preparation, library generation, methods and ideas

    thanks to post answers there.

    Comment

    Latest Articles

    Collapse

    • mylaser
      Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by mylaser
      Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
      If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
      This guide explains everything you need to know about...
      07-11-2026, 01:13 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-02-2026, 11:08 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Working...